| AstraZeneca PLC (AZN) |
GB |
$230.168B |
18.06 |
| Amgen Inc. (AMGN) |
US |
$162.778B |
15.29 |
| Gilead Sciences, Inc. (GILD) |
US |
$137.027B |
23.85 |
| Vertex Pharmaceuticals Incorporated (VRTX) |
US |
$124.348B |
0.00 |
| Bristol Myers Squibb Company (BMY) |
US |
$113.296B |
48.97 |
| CSL Limited Sponsored ADR (CSLLY) |
AU |
$79.255B |
0.00 |
| Regeneron Pharmaceuticals, Inc. (REGN) |
US |
$76.563B |
17.64 |
| GSK PLC Sponsored ADR (GSK) |
GB |
$75.939B |
9.07 |
| argenex SE (ARGX) |
NL |
$39.159B |
0.00 |
| Alnylam Pharmaceuticals, Inc. (ALNY) |
US |
$32.441B |
0.00 |
| BioNTech SE Sponsored ADR (BNTX) |
DE |
$28.771B |
0.00 |
| BeiGene, Ltd. (ONC) |
KY |
$24.990B |
0.00 |
| Biogen Inc. (BIIB) |
US |
$20.586B |
8.54 |
| Illumina, Inc. (ILMN) |
US |
$14.921B |
38.45 |
| Genmab A/S Sponsored ADR (GMAB) |
DK |
$14.784B |
18.02 |
| Insmed, Inc. (INSM) |
US |
$14.672B |
0.00 |
| Genmab A/S (GNMSF) |
DK |
$14.654B |
15.10 |
| Incyte Corporation (INCY) |
US |
$13.955B |
424.18 |
| Intra-Cellular Therapies Inc. (ITCI) |
US |
$13.674B |
0.00 |
| Moderna, Inc. (MRNA) |
US |
$13.673B |
0.00 |
| BioMarin Pharmaceutical Inc. (BMRN) |
US |
$13.007B |
25.09 |
| Swedish Orphan Biovitrum (BIOVF) |
SE |
$10.851B |
27.71 |
| Exelixis, Inc. (EXEL) |
US |
$10.314B |
21.06 |
| Bio-Techne Corp (TECH) |
US |
$10.263B |
39.35 |
| Sarepta Therapeutics, Inc. (SRPT) |
US |
$10.152B |
91.62 |
| Vaxcyte, Inc. (PCVX) |
US |
$9.939B |
0.00 |
| Ascendis Pharma A/S (ASND) |
DK |
$9.251B |
0.00 |
| Exact Sciences Corporation (EXAS) |
US |
$9.150B |
0.00 |
| Repligen Corporation (RGEN) |
US |
$8.908B |
107.43 |
| QIAGEN N.V. (QGEN) |
NL |
$8.779B |
17.70 |
| Bio-Rad Laboratories, Inc. (BIO.B) |
US |
$8.741B |
30.27 |
| Jazz Pharmaceuticals PLC (JAZZ) |
IE |
$8.222B |
8.04 |
| Zealand Pharma A/S (ZLDPF) |
DK |
$7.692B |
0.00 |
| Roivant Sciences Ltd. (ROIV) |
GB |
$7.621B |
0.00 |
| Legend Biotech Corporation Sponsored ADR (LEGN) |
US |
$7.251B |
0.00 |
| Halozyme Therapeutics, Inc. (HALO) |
US |
$7.112B |
14.73 |
| Revolution Medicines, Inc. (RVMD) |
US |
$6.954B |
0.00 |
| Axsome Therapeutics, Inc. (AXSM) |
US |
$6.717B |
0.00 |
| Telix Pharmaceuticals Limited (TLX) |
AU |
$6.569B |
0.00 |
| Cytokinetics, Incorporated (CYTK) |
US |
$5.931B |
0.00 |
| Blueprint Medicines Corporation (BPMC) |
US |
$5.895B |
0.00 |
| Alkermes plc (ALKS) |
IE |
$5.744B |
14.60 |
| Nuvalent, Inc. (NUVL) |
US |
$5.648B |
0.00 |
| Verona Pharma PLC American Depositary Share (VRNA) |
GB |
$5.561B |
0.00 |
| Krystal Biotech, Inc. (KRYS) |
US |
$5.412B |
56.58 |
| Guardant Health, Inc. (GH) |
US |
$5.291B |
0.00 |
| TG Therapeutics, Inc. (TGTX) |
US |
$4.807B |
0.00 |
| SpringWorks Therapeutics (SWTX) |
US |
$4.365B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
CH |
$4.109B |
0.00 |
| Ultragenyx Pharmaceutical Inc. (RARE) |
US |
$3.940B |
0.00 |
| PTC Therapeutics, Inc. (PTCT) |
US |
$3.909B |
0.00 |
| Viking Therapeutics, Inc. (VKTX) |
US |
$3.797B |
0.00 |
| ADMA Biologics Inc (ADMA) |
US |
$3.744B |
39.60 |
| Biohaven Ltd. (BHVN) |
US |
$3.732B |
0.00 |
| Avidity Biosciences, Inc. (RNA) |
US |
$3.713B |
0.00 |
| Alvotech (ALVO) |
LU |
$3.702B |
0.00 |
| Zai Lab Limited Unsponsored ADR (ZLAB) |
CN |
$3.696B |
0.00 |
| Akero Therapeutics, Inc. (AKRO) |
US |
$3.618B |
0.00 |
| Immunovant, Inc. (IMVT) |
US |
$3.613B |
0.00 |
| Scholar Rock Holding Corporation (SRRK) |
US |
$3.529B |
0.00 |
| Arcellx, Inc. (ACLX) |
US |
$3.447B |
0.00 |
| Rhythm Pharmaceuticals, Inc. (RYTM) |
US |
$3.446B |
0.00 |
| Apellis Pharmaceuticals, Inc. (APLS) |
US |
$3.423B |
0.00 |
| ACADIA Pharmaceuticals Inc. (ACAD) |
US |
$3.320B |
25.58 |
| Metsera Inc. (MTSR) |
US |
$3.261B |
0.00 |
| Merus N.V. (MRUS) |
NL |
$3.243B |
0.00 |
| Xenon Pharmaceuticals Inc. (XENE) |
CA |
$3.029B |
0.00 |
| Denali Therapeutics Inc. (DNLI) |
US |
$2.984B |
0.00 |
| Amicus Therapeutics, Inc. (FOLD) |
US |
$2.824B |
153.17 |
| HUTCHMED (China) Limited Sponsored ADR (HCM) |
HK |
$2.808B |
0.00 |
| MoonLake Immunotherapeutics (MLTX) |
CH |
$2.705B |
0.00 |
| Vericel Corporation (VCEL) |
US |
$2.567B |
866.67 |
| Edgewise Therapeutics, Inc. (EWTX) |
US |
$2.563B |
0.00 |
| Beam Therapeutics Inc. (BEAM) |
US |
$2.520B |
0.00 |
| Mirum Pharmaceuticals, Inc. (MIRM) |
US |
$2.518B |
0.00 |
| Arrowhead Pharmaceuticals, Inc. (ARWR) |
US |
$2.509B |
0.00 |
| Twist Bioscience Corporation (TWST) |
US |
$2.464B |
0.00 |
| NovoCure Limited (NVCR) |
JE |
$2.390B |
0.00 |
| Kymera Therapeutics, Inc. (KYMR) |
US |
$2.384B |
0.00 |
| ImmunityBio, Inc. (IBRX) |
US |
$2.383B |
0.00 |
| Protagonist Therapeutics, Inc. (PTGX) |
US |
$2.309B |
9.23 |
| Ligand Pharmaceuticals Incorporated (LGND) |
US |
$2.280B |
56.92 |
| Certara, Inc. (CERT) |
US |
$2.120B |
59.86 |
| CG Oncology, Inc. (CGON) |
US |
$2.118B |
0.00 |
| Mesoblast Limited (MESO) |
AU |
$2.080B |
0.00 |
| Agios Pharmaceuticals, Inc. (AGIO) |
US |
$2.018B |
0.00 |
| Harmony Biosciences Holdings, Inc. (HRMY) |
US |
$1.971B |
16.38 |
| IDEAYA Biosciences, Inc. (IDYA) |
US |
$1.913B |
0.00 |
| Bavarian Nordic (BVNRY) |
DK |
$1.910B |
11.70 |
| Janux Therapeutics, Inc. (JANX) |
US |
$1.890B |
0.00 |
| Ascentage Pharma Group International - Unsponsored ADR (AAPG) |
CN |
$1.843B |
0.00 |
| Tarsus Pharmaceuticals, Inc. (TARS) |
US |
$1.829B |
0.00 |
| Belite Bio, Inc. Sponsored ADR (BLTE) |
US |
$1.815B |
0.00 |
| Vera Therapeutics, Inc. (VERA) |
US |
$1.810B |
0.00 |
| Galapagos NV (GLPG) |
BE |
$1.762B |
0.00 |
| Iovance Biotherapeutics, Inc. (IOVA) |
US |
$1.762B |
0.00 |
| Travere Therapeutics, Inc. (TVTX) |
US |
$1.716B |
0.00 |
| WAVE Life Sciences Ltd. (WVE) |
SG |
$1.698B |
0.00 |
| Dynavax Technologies Corporation (DVAX) |
US |
$1.654B |
74.06 |
| Disc Medicine, Inc. (IRON) |
US |
$1.623B |
0.00 |
| MannKind Corporation (MNKD) |
US |
$1.588B |
41.14 |
| Apogee Therapeutics Inc. (APGE) |
US |
$1.556B |
0.00 |
| Geron Corporation (GERN) |
US |
$1.554B |
0.00 |
| Arcutis Biotherapeutics, Inc. (ARQT) |
US |
$1.524B |
0.00 |
| Immunocore Holdings PLC Sponsored ADR (IMCR) |
GB |
$1.497B |
0.00 |
| Celldex Therapeutics, Inc. (CLDX) |
US |
$1.490B |
0.00 |
| Kiniksa Pharmaceuticals, Ltd. (KNSA) |
GB |
$1.445B |
0.00 |
| NeoGenomics, Inc. (NEO) |
US |
$1.426B |
0.00 |
| Syndax Pharmaceuticals, Inc. (SNDX) |
US |
$1.398B |
0.00 |
| Praxis Precision Medicines, Inc. (PRAX) |
US |
$1.388B |
0.00 |
| GRAIL, Inc. (GRAL) |
US |
$1.369B |
0.00 |
| Liquidia Technologies, Inc. (LQDA) |
US |
$1.364B |
0.00 |
| Structure Therapeutics Inc. Sponsored ADR (GPCR) |
US |
$1.361B |
0.00 |
| Fortrea Holdings Inc. (FTRE) |
US |
$1.335B |
42.51 |
| Vir Biotechnology, Inc. (VIR) |
US |
$1.318B |
0.00 |
| Myriad Genetics, Inc. (MYGN) |
US |
$1.291B |
0.00 |
| Viridian Therapeutics, Inc. (VRDN) |
US |
$1.289B |
0.00 |
| Nurix Therapeutics, Inc. (NRIX) |
US |
$1.280B |
0.00 |
| Novavax, Inc. (NVAX) |
US |
$1.280B |
0.00 |
| Day One Biopharmaceuticals, Inc. (DAWN) |
US |
$1.254B |
0.00 |
| Intellia Therapeutics, Inc. (NTLA) |
US |
$1.240B |
0.00 |
| Arvinas, Inc. (ARVN) |
US |
$1.222B |
0.00 |
| Adaptive Biotechnologies Corporation (ADPT) |
US |
$1.220B |
0.00 |
| ANI Pharmaceuticals, Inc. (ANIP) |
US |
$1.218B |
16.60 |
| 89BIO (ETNB) |
US |
$1.174B |
0.00 |
| MiMedx Group, Inc (MDXG) |
US |
$1.173B |
30.69 |
| Arcus Biosciences, Inc. (RCUS) |
US |
$1.164B |
0.00 |
| Pacira BioSciences, Inc. (PCRX) |
US |
$1.162B |
10.94 |
| Spyre Therapeutics, Inc. (SYRE) |
US |
$1.095B |
0.00 |
| Gyre Therapeutics, Inc. (GYRE) |
US |
$1.079B |
0.00 |
| Replimune Group, Inc. (REPL) |
US |
$1.077B |
0.00 |
| Zymeworks Inc. (ZYME) |
US |
$0.991B |
0.00 |
| Rocket Pharmaceuticals, Inc. (RCKT) |
US |
$0.954B |
0.00 |
| ArriVent BioPharma, Inc. (AVBP) |
US |
$0.912B |
0.00 |
| AbCellera Biologics Inc. (ABCL) |
CA |
$0.895B |
0.00 |
| Cogent Biosciences, Inc. (COGT) |
US |
$0.884B |
0.00 |
| Oculis Holding AG (OCS) |
CH |
$0.867B |
0.00 |
| Pharvaris N.V. (PHVS) |
NL |
$0.862B |
0.00 |
| Sionna Therapeutics, Inc. (SION) |
|
$0.840B |
0.00 |
| Prothena Corporation plc (PRTA) |
IE |
$0.837B |
0.00 |
| Bicycle Therapeutics PLC Sponsored ADR (BCYC) |
GB |
$0.805B |
0.00 |
| Opthea Limited Unsponsored ADR (OPT) |
AU |
$0.773B |
0.00 |
| Immunome, Inc. (IMNM) |
US |
$0.759B |
0.00 |
| Nuvation Bio Inc. (NUVB) |
US |
$0.744B |
0.00 |
| CureVac N.V. (CVAC) |
DE |
$0.739B |
6.00 |
| Castle Biosciences, Inc. (CSTL) |
US |
$0.721B |
128.75 |
| Anavex Life Sciences Corp. (AVXL) |
US |
$0.710B |
0.00 |
| Bicara Therapeutics Inc. (BCAX) |
US |
$0.707B |
0.00 |
| Dianthus Therapeutics, Inc. (DNTH) |
US |
$0.701B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
CH |
$0.696B |
0.00 |
| Sana Biotechnology, Inc. (SANA) |
US |
$0.672B |
0.00 |
| Tyra Biosciences, Inc. (TYRA) |
US |
$0.666B |
0.00 |
| Cytek Biosciences, Inc. (CTKB) |
US |
$0.660B |
0.00 |
| GH Research PLC (GHRS) |
IE |
$0.651B |
0.00 |
| Arbutus Biopharma Corporation (ABUS) |
US |
$0.648B |
0.00 |
| LENZ Therapeutics, Inc. (LENZ) |
US |
$0.646B |
0.00 |
| Sinovac Biotech, Ltd. (SVA) |
CN |
$0.645B |
0.00 |
| Kura Oncology, Inc. (KURA) |
US |
$0.642B |
0.00 |
| uniQure N.V. (QURE) |
NL |
$0.626B |
0.00 |
| Ginkgo Bioworks Holdings, Inc. (DNA) |
US |
$0.622B |
0.00 |
| CorMedix Inc (CRMD) |
US |
$0.615B |
0.00 |
| Pharming Group N.V. Sponsored ADR (PHAR) |
NL |
$0.603B |
0.00 |
| Pharming Group NV (PHGUF) |
NL |
$0.587B |
0.00 |
| MeiraGTx Holdings PLC (MGTX) |
US |
$0.571B |
0.00 |
| Absci Corporation (ABSI) |
US |
$0.570B |
0.00 |
| AnaptysBio, Inc. (ANAB) |
US |
$0.566B |
0.00 |
| Mind Medicine (MindMed) Inc. (MNMD) |
US |
$0.560B |
0.00 |
| Precigen, Inc. (PGEN) |
US |
$0.559B |
0.00 |
| Immatics N.V. (IMTX) |
DE |
$0.549B |
0.00 |
| Oric Pharmaceuticals, Inc. (ORIC) |
US |
$0.545B |
0.00 |
| Maze Therapeutics, Inc. (MAZE) |
US |
$0.529B |
0.00 |
| Cullinan Therapeutics, Inc. (CGEM) |
US |
$0.526B |
0.00 |
| Autolus Therapeutics PLC Sponsored ADR (AUTL) |
GB |
$0.519B |
0.00 |
| Abivax SA Sponsored ADR (ABVX) |
FR |
$0.512B |
0.00 |
| Cartesian Therapeutics, Inc. (RNAC) |
US |
$0.489B |
0.00 |
| Celcuity, Inc. (CELC) |
US |
$0.488B |
0.00 |
| Entrada Therapeutics, Inc. (TRDA) |
US |
$0.488B |
8.20 |
| Arcturus Therapeutics Holdings Inc. (ARCT) |
US |
$0.481B |
0.00 |
| Mineralys Therapeutics, Inc. (MLYS) |
US |
$0.476B |
0.00 |
| Oxford BioMedica (OXBDF) |
GB |
$0.466B |
0.00 |
| Rapport Therapeutics, Inc. (RAPP) |
US |
$0.464B |
0.00 |
| Chimerix, Inc. (CMRX) |
US |
$0.463B |
0.00 |
| Allogene Therapeutics, Inc. (ALLO) |
US |
$0.455B |
0.00 |
| Sage Therapeutics, Inc. (SAGE) |
US |
$0.449B |
0.00 |
| Keros Therapeutics, Inc. (KROS) |
US |
$0.446B |
0.00 |
| Humacyte, Inc. (HUMA) |
US |
$0.446B |
0.00 |
| PureTech Health PLC Sponsored ADR (PRTC) |
US |
$0.442B |
0.00 |
| Mereo BioPharma Group plc - Sponsored ADR (MREO) |
GB |
$0.442B |
0.00 |
| Stoke Therapeutics, Inc. (STOK) |
US |
$0.441B |
0.00 |
| Tectonic Therapeutic, Inc. (TECX) |
US |
$0.436B |
0.00 |
| Kamada Ltd. (KMDA) |
IL |
$0.429B |
26.64 |
| Upstream Bio, Inc. (UPB) |
US |
$0.428B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC. (EYPT) |
US |
$0.420B |
0.00 |
| Emergent Biosolutions Inc. (EBS) |
US |
$0.418B |
0.00 |
| ChromaDex Corporation (CDXC) |
US |
$0.414B |
542.00 |
| MaxCyte, Inc. (MXCT) |
US |
$0.408B |
0.00 |
| Compass Therapeutics, Inc. (CMPX) |
US |
$0.402B |
0.00 |
| Erasca, Inc. (ERAS) |
US |
$0.399B |
0.00 |
| Alpha Teknova, Inc. (TKNO) |
US |
$0.397B |
0.00 |
| Prime Medicine, Inc. (PRME) |
US |
$0.389B |
0.00 |
| Phathom Pharmaceuticals, Inc. (PHAT) |
US |
$0.388B |
0.00 |
| Astria Therapeutics, Inc. (ATXS) |
US |
$0.384B |
0.00 |
| Monte Rosa Therapeutics, Inc. (GLUE) |
US |
$0.382B |
0.00 |
| Eton Pharmaceuticals, Inc. (ETON) |
US |
$0.378B |
0.00 |
| Candel Therapeutics, Inc. (CADL) |
US |
$0.378B |
0.00 |
| Aura Biosciences, Inc. (AURA) |
US |
$0.375B |
0.00 |
| MBX Biosciences, Inc. (MBX) |
US |
$0.364B |
0.00 |
| aTyr Pharma, Inc. (ATYR) |
US |
$0.363B |
0.00 |
| REGENXBIO Inc. (RGNX) |
US |
$0.360B |
0.00 |
| Trevi Therapeutics, Inc. (TRVI) |
US |
$0.354B |
0.00 |
| Terns Pharmaceuticals, Inc. (TERN) |
US |
$0.340B |
0.00 |
| Codexis, Inc. (CDXS) |
US |
$0.340B |
0.00 |
| Northwest Biotherapeutics, Inc. (NWBO) |
US |
$0.332B |
0.00 |
| Zenas BioPharma, Inc. (ZBIO) |
US |
$0.327B |
0.00 |
| Gossamer Bio, Inc. (GOSS) |
US |
$0.317B |
0.00 |
| Annexon, Inc. (ANNX) |
US |
$0.300B |
0.00 |
| Foghorn Therapeutics Inc. (FHTX) |
US |
$0.291B |
0.00 |
| Neumora Therapeutics, Inc. (NMRA) |
US |
$0.291B |
0.00 |
| Olema Pharmaceuticals, Inc. (OLMA) |
US |
$0.286B |
0.00 |
| Prima BioMed Ltd (IMMP) |
AU |
$0.279B |
0.00 |
| DiaMedica Therapeutics, Inc. (DMAC) |
US |
$0.278B |
0.00 |
| enGene Holdings Inc. (ENGN) |
CA |
$0.278B |
0.00 |
| Design Therapeutics, Inc. (DSGN) |
US |
$0.278B |
0.00 |
| XOMA Royalty Corporation (XOMA) |
US |
$0.277B |
0.00 |
| Rezolute, Inc. (RZLT) |
US |
$0.274B |
0.00 |
| iTeos Therapeutics, Inc. (ITOS) |
US |
$0.271B |
0.00 |
| Corvus Pharmaceuticals, Inc. (CRVS) |
US |
$0.269B |
0.00 |
| Benitec Biopharma Limited (BNTC) |
US |
$0.265B |
0.00 |
| AC Immune (ACIU) |
CH |
$0.262B |
0.00 |
| Atea Pharmaceuticals, Inc. (AVIR) |
US |
$0.261B |
0.00 |
| ACELYRIN, INC. (SLRN) |
US |
$0.261B |
0.00 |
| Vanda Pharmaceuticals Inc. (VNDA) |
US |
$0.258B |
0.00 |
| Neurogene Inc. (NGNE) |
US |
$0.258B |
0.00 |
| Septerna, Inc. (SEPN) |
US |
$0.258B |
0.00 |
| Eledon Pharmaceuticals, Inc. (ELDN) |
US |
$0.256B |
0.00 |
| Y-mAbs Therapeutics, Inc. (YMAB) |
US |
$0.256B |
0.00 |
| Anika Therapeutics Inc. (ANIK) |
US |
$0.255B |
0.00 |
| Bright Minds Biosciences Inc. (DRUG) |
US |
$0.254B |
0.00 |
| Tango Therapeutics, Inc. (TNGX) |
US |
$0.254B |
0.00 |
| Verastem, Inc. (VSTM) |
US |
$0.253B |
0.00 |
| Abeona Therapeutics Inc. (ABEO) |
US |
$0.251B |
0.00 |
| Semper Paratus Acquisition Corporation (TVGN) |
US |
$0.248B |
0.00 |
| Monopar Therapeutics Inc. (MNPR) |
US |
$0.246B |
0.00 |
| Alumis Inc. (ALMS) |
US |
$0.244B |
0.00 |
| Cardiff Oncology, Inc. (CRDF) |
US |
$0.243B |
0.00 |
| Amarin Corporation PLC (AMRN) |
IE |
$0.242B |
0.00 |
| Urogen Pharma (URGN) |
US |
$0.236B |
0.00 |
| Solid Biosciences Inc. (SLDB) |
US |
$0.235B |
0.00 |
| Kodiak Sciences Inc. (KOD) |
US |
$0.234B |
0.00 |
| Voyager Therapeutics, Inc. (VYGR) |
US |
$0.231B |
5.94 |
| BioStem Technologies, Inc. (BSEM) |
|
$0.230B |
20.29 |
| Sangamo Therapeutics, Inc. (SGMO) |
US |
$0.223B |
0.00 |
| Zhengye Biotechnology Holding Limited (ZYBT) |
CN |
$0.218B |
0.00 |
| Palvella Therapeutics, Inc. (PVLA) |
US |
$0.216B |
0.00 |
| C4 Therapeutics, Inc. (CCCC) |
US |
$0.212B |
0.00 |
| Invivyd, Inc. (IVVD) |
US |
$0.212B |
0.00 |
| ProQR Therapeutics N.V. (PRQR) |
NL |
$0.209B |
0.00 |
| Lifecore Biomedical, Inc. (LFCR) |
US |
$0.208B |
0.00 |
| Fulcrum Therapeutics, Inc. (FULC) |
US |
$0.208B |
0.00 |
| Ocugen, Inc. (OCGN) |
US |
$0.198B |
0.00 |
| Contineum Therapeutics, Inc. (CTNM) |
US |
$0.196B |
0.00 |
| Nautilus Biotechnology, Inc. (NAUT) |
US |
$0.193B |
0.00 |
| GENFIT S.A. Unsponsored ADR (GNFT) |
FR |
$0.191B |
0.00 |
| INmune Bio, Inc. (INMB) |
US |
$0.190B |
0.00 |
| Molecular Partners AG Sponsored ADR (MOLN) |
CH |
$0.189B |
0.00 |
| Innate Pharma S.A. Sponsored ADR (IPHA) |
FR |
$0.188B |
0.00 |
| Pliant Therapeutics, Inc. (PLRX) |
US |
$0.187B |
0.00 |
| Compugen Ltd. (CGEN) |
IL |
$0.187B |
105.00 |
| Adocia (ADOCY) |
FR |
$0.187B |
0.00 |
| Adherex Technologies Inc. (FENC) |
US |
$0.183B |
0.00 |
| Alector, Inc. (ALEC) |
US |
$0.183B |
0.00 |
| Inhibrx Biosciences, Inc. (INBX) |
US |
$0.182B |
0.00 |
| Orchestra BioMed Holdings, Inc. (OBIO) |
US |
$0.179B |
0.00 |
| Lexicon Pharmaceuticals, Inc. (LXRX) |
US |
$0.175B |
0.00 |
| CARGO Therapeutics, Inc. (CRGX) |
US |
$0.174B |
0.00 |
| Genelux Corporation (GNLX) |
US |
$0.166B |
0.00 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) |
US |
$0.165B |
0.00 |
| scPharmaceuticals, Inc. (SCPH) |
US |
$0.163B |
0.00 |
| Fate Therapeutics, Inc. (FATE) |
US |
$0.162B |
0.00 |
| BioAge Labs, Inc. (BIOA) |
US |
$0.161B |
0.00 |
| Editas Medicine, Inc. (EDIT) |
US |
$0.158B |
0.00 |
| ADC Therapeutics SA (ADCT) |
CH |
$0.158B |
0.00 |
| Greenwich LifeSciences, Inc. (GLSI) |
US |
$0.157B |
0.00 |
| Third Harmonic Bio, Inc. (THRD) |
US |
$0.156B |
0.00 |
| Checkpoint Therapeutics, Inc. (CKPT) |
US |
$0.153B |
0.00 |
| Cidara Therapeutics, Inc. (CDTX) |
US |
$0.152B |
0.00 |
| Actuate Therapeutics, Inc. (ACTU) |
US |
$0.150B |
0.00 |
| Inventiva S.A. Sponsored ADR (IVA) |
FR |
$0.149B |
0.00 |
| Nuvectis Pharma, Inc. (NVCT) |
US |
$0.147B |
0.00 |
| Sutro Biopharma, Inc. (STRO) |
US |
$0.146B |
0.00 |
| Nkarta, Inc. (NKTX) |
US |
$0.145B |
0.00 |
| Instil Bio, Inc. (TIL) |
US |
$0.144B |
0.00 |
| Adaptimmune Therapeutics PLC (ADAP) |
GB |
$0.143B |
0.00 |
| Puma Biotechnology, Inc. (PBYI) |
US |
$0.143B |
6.05 |
| TuHURA Biosciences, Inc. (HURA) |
US |
$0.141B |
0.00 |
| Seres Therapeutics, Inc. (MCRB) |
US |
$0.137B |
0.00 |
| Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) |
GB |
$0.136B |
0.00 |
| 2seventy bio, Inc. (TSVT) |
US |
$0.135B |
0.00 |
| Seer, Inc. (SEER) |
US |
$0.133B |
0.00 |
| Renovaro Inc. (RENB) |
US |
$0.131B |
0.00 |
| Eupraxia Pharmaceuticals Inc. (EPRX) |
CA |
$0.130B |
0.00 |
| Sagimet Biosciences Inc. (SGMT) |
US |
$0.126B |
0.00 |
| Biomea Fusion, Inc. (BMEA) |
US |
$0.125B |
0.00 |
| Coherus BioSciences, Inc. (CHRS) |
US |
$0.124B |
0.00 |
| Vigil Neuroscience, Inc. (VIGL) |
US |
$0.124B |
0.00 |
| InflaRx N.V. (IFRX) |
DE |
$0.123B |
0.00 |
| Black Diamond Therapeutics, Inc. (BDTX) |
US |
$0.122B |
0.00 |
| Kyverna Therapeutics, Inc. (KYTX) |
US |
$0.120B |
0.00 |
| Caribou Biosciences, Inc. (CRBU) |
US |
$0.119B |
0.00 |
| TScan Therapeutics, Inc. (TCRX) |
US |
$0.116B |
0.00 |
| Immunic, Inc. (IMUX) |
US |
$0.114B |
0.00 |
| Ventyx Biosciences, Inc. (VTYX) |
US |
$0.114B |
0.00 |
| Elutia Inc. (ELUT) |
US |
$0.111B |
0.00 |
| eXoZymes Inc. (EXOZ) |
US |
$0.111B |
0.00 |
| Milestone Pharmaceuticals Inc. (MIST) |
CA |
$0.109B |
0.00 |
| TELA Bio, Inc. (TELA) |
US |
$0.107B |
0.00 |
| Coya Therapeutics, Inc. (COYA) |
US |
$0.107B |
0.00 |
| Akoya Biosciences, Inc. (AKYA) |
US |
$0.102B |
0.00 |
| Cabaletta Bio, Inc. (CABA) |
US |
$0.101B |
0.00 |
| Alpha Cognition Inc. (ACOG) |
CA |
$0.101B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
US |
$0.099B |
0.00 |
| Climb Bio, Inc. (CLYM) |
US |
$0.099B |
0.00 |
| BioHarvest Sciences Inc. (BHST) |
CA |
$0.098B |
0.00 |
| CAMP4 Therapeutics Corporation (CAMP) |
US |
$0.097B |
0.00 |
| Rani Therapeutics Holdings, Inc. (RANI) |
US |
$0.095B |
0.00 |
| Vor Biopharma Inc. (VOR) |
|
$0.094B |
0.00 |
| Elicio Therapeutics, Inc. (ELTX) |
US |
$0.092B |
0.00 |
| Artiva Biotherapeutics, Inc. (ARTV) |
US |
$0.092B |
0.00 |
| Zura Bio Limited (ZURA) |
US |
$0.091B |
0.00 |
| Adagene Inc. Sponsored ADR (ADAG) |
CN |
$0.091B |
0.00 |
| XBiotech Inc. (XBIT) |
US |
$0.091B |
0.00 |
| HilleVax, Inc. (HLVX) |
US |
$0.091B |
0.00 |
| Skye Bioscience, Inc. (SKYE) |
US |
$0.090B |
0.00 |
| DBV Technologies S.A. (DBVT) |
FR |
$0.090B |
0.00 |
| MediciNova, Inc. (MNOV) |
US |
$0.090B |
0.00 |
| Jasper Therapeutics, Inc. (JSPR) |
US |
$0.089B |
0.00 |
| Galena Biopharma, Inc. (SLS) |
US |
$0.089B |
0.00 |
| Tenaya Therapeutics, Inc. (TNYA) |
US |
$0.088B |
0.00 |
| Tiziana Life Sciences Ltd (TLSA) |
GB |
$0.086B |
0.00 |
| Alto Neuroscience, Inc. (ANRO) |
US |
$0.086B |
0.00 |
| Cellectis S.A. (CLLS) |
FR |
$0.085B |
0.00 |
| Theratechnologies Inc. (THTX) |
CA |
$0.085B |
0.00 |
| VistaGen Therapeutics, Inc. (VTGN) |
US |
$0.085B |
0.00 |
| Citius Oncology, Inc. (CTOR) |
US |
$0.084B |
0.00 |
| Cue Biopharma, Inc. (CUE) |
US |
$0.084B |
0.00 |
| Acumen Pharmaceuticals, Inc. (ABOS) |
US |
$0.084B |
0.00 |
| Adlai Nortye Ltd. Sponsored ADR (ANL) |
KY |
$0.082B |
0.00 |
| IGM Biosciences, Inc. (IGMS) |
US |
$0.082B |
0.00 |
| Adverum Biotechnologies, Inc. (ADVM) |
US |
$0.082B |
0.00 |
| Inozyme Pharma, Inc. (INZY) |
US |
$0.080B |
0.00 |
| Scilex Holding Company (SCLX) |
US |
$0.080B |
0.00 |
| Adicet Bio, Inc. (ACET) |
US |
$0.080B |
0.00 |
| ZIVO Bioscience, Inc. (ZIVO) |
US |
$0.080B |
0.00 |
| X4 Pharmaceuticals, Inc. (XFOR) |
US |
$0.080B |
0.00 |
| I-Mab Sponsored ADR (IMAB) |
CN |
$0.079B |
0.00 |
| Entera Bio Ltd. (ENTX) |
IL |
$0.075B |
0.00 |
| IO Biotech, Inc. (IOBT) |
DK |
$0.072B |
0.00 |
| Genenta Science S.p.A. Unsponsored ADR (GNTA) |
IT |
$0.072B |
0.00 |
| Clearside Biomedical, Inc. (CLSD) |
US |
$0.072B |
0.00 |
| Forte Biosciences, Inc. (FBRX) |
US |
$0.070B |
0.00 |
| BeyondSpring Inc. (BYSI) |
US |
$0.070B |
0.00 |
| Aadi Bioscience, Inc. (AADI) |
US |
$0.069B |
0.00 |
| Aerovate Therapeutics, Inc. (AVTE) |
US |
$0.068B |
0.00 |
| Ikena Oncology, Inc. (IKNA) |
US |
$0.067B |
0.00 |
| Aligos Therapeutics, Inc. (ALGS) |
US |
$0.067B |
0.00 |
| Mersana Therapeutics, Inc. (MRSN) |
US |
$0.066B |
0.00 |
| Shattuck Labs, Inc. (STTK) |
US |
$0.065B |
0.00 |
| Prenetics Global Limited (PRE) |
HK |
$0.065B |
0.00 |
| 23andMe Holding Co. (ME) |
US |
$0.065B |
0.00 |
| vTv Therapeutics Inc. (VTVT) |
US |
$0.064B |
0.00 |
| Oncolytics Biotech Inc. (ONCY) |
CA |
$0.062B |
0.00 |
| Applied Therapeutics Inc. (APLT) |
US |
$0.062B |
0.00 |
| Quince Therapeutics, Inc. (QNCX) |
US |
$0.062B |
0.00 |
| Werewolf Therapeutics, Inc. (HOWL) |
US |
$0.062B |
0.00 |
| CytomX Therapeutics, Inc. (CTMX) |
US |
$0.061B |
4.59 |
| Kronos Bio, Inc. (KRON) |
US |
$0.060B |
0.00 |
| ALX Oncology Holdings Inc. (ALXO) |
US |
$0.059B |
0.00 |
| BGM Group Ltd. (BGM) |
CN |
$0.059B |
0.00 |
| Regencell Bioscience Holdings Limited (RGC) |
HK |
$0.059B |
0.00 |
| Rein Therapeutics Inc. (RNTX) |
US |
$0.059B |
0.00 |
| Inovio Pharmaceuticals, Inc. (INO) |
US |
$0.058B |
0.00 |
| Achilles Therapeutics PLC Sponsored ADR (ACHL) |
GB |
$0.057B |
0.00 |
| Repare Therapeutics Inc. (RPTX) |
CA |
$0.055B |
0.00 |
| Immuneering Corporation (IMRX) |
US |
$0.055B |
0.00 |
| Estrella Immunopharma, Inc. (ESLA) |
US |
$0.054B |
0.00 |
| Anebulo Pharmaceuticals, Inc. (ANEB) |
US |
$0.052B |
0.00 |
| PDS Biotechnology Corporation (PDSB) |
US |
$0.050B |
0.00 |
| Oncobiologics, Inc. (OTLK) |
US |
$0.050B |
0.00 |
| Immix Biopharma, Inc. (IMMX) |
US |
$0.048B |
0.00 |
| Connect Biopharma Holdings Limited Sponsored ADR (CNTB) |
US |
$0.048B |
0.00 |
| Lantern Pharma Inc. (LTRN) |
US |
$0.047B |
0.00 |
| Precision BioSciences, Inc. (DTIL) |
US |
$0.045B |
0.00 |
| Spero Therapeutics, Inc. (SPRO) |
US |
$0.045B |
11.87 |
| Fortress Biotech, Inc. (FBIO) |
US |
$0.045B |
0.00 |
| PepGen, Inc. (PEPG) |
US |
$0.045B |
0.00 |
| Kezar Life Sciences, Inc. (KZR) |
US |
$0.044B |
0.00 |
| Grace Therapeutics, Inc. (GRCE) |
CA |
$0.044B |
0.00 |
| Ovid Therapeutics (OVID) |
US |
$0.044B |
0.00 |
| Boundless Bio, Inc. (BOLD) |
US |
$0.044B |
0.00 |
| Rapt Therapeutics (RAPT) |
US |
$0.044B |
0.00 |
| Dyadic International Inc. (DYAI) |
US |
$0.044B |
0.00 |
| Medicus Pharma Ltd (MDCX) |
CA |
$0.043B |
0.00 |
| Abpro Holdings Inc. (ABP) |
US |
$0.043B |
0.00 |
| FibroBiologics Inc. (FBLG) |
US |
$0.041B |
0.00 |
| Atara Biotherapeutics, Inc. (ATRA) |
US |
$0.041B |
0.00 |
| Xilio Therapeutics, Inc. (XLO) |
US |
$0.041B |
0.00 |
| Generation Bio Co. (GBIO) |
US |
$0.041B |
0.00 |
| KALA BIO, Inc. (KALA) |
US |
$0.040B |
0.00 |
| Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) |
GB |
$0.040B |
0.00 |
| MiNK Therapeutics, Inc. (INKT) |
US |
$0.040B |
0.00 |
| Celularity, Inc. (CELU) |
US |
$0.040B |
0.00 |
| CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) |
IL |
$0.040B |
0.00 |
| bluebird bio, Inc. (BLUE) |
US |
$0.040B |
0.00 |
| OKYO Pharma Limited Sponsored ADR (OKYO) |
|
$0.038B |
0.00 |
| Femasys Inc. (FEMY) |
US |
$0.038B |
0.00 |
| Clene Inc. (CLNN) |
US |
$0.037B |
0.00 |
| Elevation Oncology, Inc. (ELEV) |
US |
$0.036B |
0.00 |
| Alterity Therapeutics Limited - Sponsored ADR (ATHE) |
AU |
$0.036B |
0.00 |
| Cadrenal Therapeutics, Inc. (CVKD) |
US |
$0.035B |
0.00 |
| Opus Genetics, Inc. (IRD) |
US |
$0.035B |
0.00 |
| Coeptis Therapeutics Holdings, Inc. (COEP) |
US |
$0.034B |
0.00 |
| AN2 Therapeutics, Inc. (ANTX) |
US |
$0.034B |
0.00 |
| Intensity Therapeutics Inc. (INTS) |
US |
$0.034B |
0.00 |
| UNITY Biotechnology, Inc. (UBX) |
US |
$0.033B |
0.00 |
| Pulmatrix, Inc. (PULM) |
US |
$0.033B |
0.00 |
| Passage Bio, Inc. (PASG) |
US |
$0.032B |
0.00 |
| CalciMedica Inc. (CALC) |
US |
$0.032B |
0.00 |
| Q32 Bio Inc. (QTTB) |
US |
$0.031B |
0.00 |
| Rallybio Corporation (RLYB) |
US |
$0.031B |
0.00 |
| Equillium, Inc. (EQ) |
US |
$0.031B |
0.00 |
| CytoMed Therapeutics Limited (GDTC) |
SG |
$0.031B |
0.00 |
| Annovis Bio, Inc. (ANVS) |
US |
$0.030B |
0.00 |
| Pluri Inc. (PLUR) |
IL |
$0.030B |
0.00 |
| Cyclo Therapeutics, Inc. (CYTH) |
US |
$0.030B |
0.00 |
| Dare Bioscience, Inc. (DARE) |
US |
$0.028B |
0.00 |
| Enzo Biochem, Inc. (ENZ) |
US |
$0.027B |
0.00 |
| Promis Neurosciences (PMN) |
CA |
$0.027B |
0.00 |
| Cardio Diagnostics Holdings, Inc. (CDIO) |
US |
$0.026B |
0.00 |
| Curis, Inc. (CRIS) |
US |
$0.026B |
0.00 |
| Onconetix, Inc. (ONCO) |
US |
$0.026B |
0.00 |
| Akari Therapeutics PLC (AKTX) |
GB |
$0.026B |
0.00 |
| NKGen Biotech, Inc. (NKGN) |
US |
$0.026B |
0.00 |
| Allakos Inc. (ALLK) |
US |
$0.026B |
0.00 |
| Lexaria Bioscience Corp. (LEXX) |
CA |
$0.025B |
0.00 |
| LAVA Therapeutics N.V. (LVTX) |
NL |
$0.025B |
0.00 |
| RenovoRx, Inc. (RNXT) |
US |
$0.025B |
0.00 |
| Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) |
IL |
$0.025B |
0.00 |
| Cognition Therapeutics, Inc. (CGTX) |
US |
$0.024B |
0.00 |
| Beyond Air, Inc. (XAIR) |
US |
$0.024B |
0.00 |
| Longeveron Inc. (LGVN) |
US |
$0.023B |
0.00 |
| Tenax Therapeutics, Inc. (TENX) |
US |
$0.023B |
0.00 |
| Cara Therapeutics, Inc. (CARA) |
US |
$0.023B |
0.00 |
| Exicure, Inc. (XCUR) |
US |
$0.022B |
0.00 |
| HOOKIPA Pharma Inc. (HOOK) |
US |
$0.021B |
0.00 |
| Lisata Therapeutics, Inc. (LSTA) |
US |
$0.021B |
0.00 |
| LakeShore Biopharma Co., Ltd. (LSB) |
CN |
$0.021B |
0.00 |
| NextCure, Inc. (NXTC) |
US |
$0.020B |
0.00 |
| Cocrystal Pharma, Inc. (COCP) |
US |
$0.020B |
0.00 |
| BioAtla, Inc. (BCAB) |
US |
$0.020B |
0.00 |
| IN8bio, Inc. (INAB) |
US |
$0.020B |
0.00 |
| Senti Biosciences, Inc. (SNTI) |
US |
$0.019B |
0.00 |
| Bolt Biotherapeutics, Inc. (BOLT) |
US |
$0.019B |
0.00 |
| Leap Therapeutics, Inc. (LPTX) |
US |
$0.018B |
0.00 |
| OnKure Therapeutics, Inc. (OKUR) |
US |
$0.018B |
0.00 |
| MIRA Pharmaceuticals, Inc. (MIRA) |
US |
$0.018B |
0.00 |
| Gelteq Limited (GELS) |
AU |
$0.018B |
0.00 |
| HCW Biologics Inc. (HCWB) |
US |
$0.017B |
0.00 |
| Spruce Biosciences, Inc. (SPRB) |
US |
$0.017B |
0.00 |
| Edesa Biotech, Inc. (EDSA) |
CA |
$0.017B |
0.00 |
| SAB Biotherapeutics, Inc. (SABS) |
US |
$0.017B |
0.00 |
| Athira Pharma, Inc. (ATHA) |
US |
$0.017B |
0.00 |
| Affimed N.V. (AFMD) |
DE |
$0.017B |
0.00 |
| BRIACELL THERAP (BCTX) |
CA |
$0.016B |
0.00 |
| Synlogic, Inc. (SYBX) |
US |
$0.016B |
0.00 |
| GeoVax Labs Inc. (GOVX) |
US |
$0.016B |
0.00 |
| NeuroSense Therapeutics Ltd. (NRSN) |
IL |
$0.015B |
0.00 |
| Aprea Therapeutics, Inc. (APRE) |
US |
$0.014B |
0.00 |
| CervoMed Inc. (CRVO) |
US |
$0.014B |
0.00 |
| MetaVia Inc. (MTVA) |
US |
$0.014B |
0.00 |
| Cingulate Inc. (CING) |
US |
$0.014B |
0.00 |
| Acurx Pharmaceuticals, Inc. (ACXP) |
US |
$0.013B |
0.00 |
| Imunon, Inc. (IMNN) |
US |
$0.013B |
0.00 |
| bioAffinity Technologies, Inc. (BIAF) |
US |
$0.013B |
0.00 |
| Biorestorative Therapies, Inc. (BRTX) |
US |
$0.012B |
0.00 |
| Quantum Biopharma Ltd. (QNTM) |
CA |
$0.012B |
0.00 |
| Mainz Biomed NV (MYNZ) |
DE |
$0.011B |
0.00 |
| Sensei Biotherapeutics, Inc. (SNSE) |
US |
$0.011B |
0.00 |
| IMMURON (IMRN) |
AU |
$0.011B |
0.00 |
| BioCardia, Inc. (BCDA) |
US |
$0.011B |
0.00 |
| Bionano Genomics, Inc. (BNGO) |
US |
$0.010B |
0.00 |
| Aptose Biosciences, Inc. (APTO) |
CA |
$0.010B |
0.00 |
| COSCIENS Biopharma Inc. (CSCI) |
CA |
$0.010B |
0.00 |
| Brainstorm Cell Therapeutics Inc. (BCLI) |
US |
$0.010B |
0.00 |
| Creative Medical Technology Holdings, Inc. (CELZ) |
US |
$0.009B |
0.00 |
| ABVC BioPharma, Inc. (ABVC) |
US |
$0.009B |
0.00 |
| Turnstone Biologics Corp. (TSBX) |
US |
$0.009B |
0.00 |
| Omega Therapeutics, Inc. (OMGA) |
US |
$0.009B |
0.00 |
| Biofrontera Inc. (BFRI) |
US |
$0.009B |
0.00 |
| Psyence Biomedical Ltd. (PBM) |
CA |
$0.009B |
0.00 |
| Neuphoria Therapeutics Inc. (NEUP) |
AU |
$0.009B |
0.00 |
| Aytu BioPharma Inc. (AYTU) |
US |
$0.008B |
0.00 |
| Cyclerion Therapeutics, Inc. (CYCN) |
US |
$0.008B |
0.00 |
| Apollomics Inc. (APLM) |
US |
$0.008B |
0.00 |
| Evogene Ltd. (EVGN) |
IL |
$0.008B |
0.00 |
| Hoth Therapeutics, Inc. (HOTH) |
US |
$0.007B |
0.00 |
| Dogwood Therapeutics, Inc (DWTX) |
US |
$0.007B |
0.00 |
| Silexion Therapeutics Corp (SLXN) |
IL |
$0.007B |
0.00 |
| Ensysce Biosciences, Inc. (ENSC) |
US |
$0.007B |
0.00 |
| BioXcel Therapeutics, Inc. (BTAI) |
US |
$0.007B |
0.00 |
| Organovo Holdings, Inc. (ONVO) |
US |
$0.006B |
0.00 |
| Soligenix Inc. (SNGX) |
US |
$0.006B |
0.00 |
| Silo Pharma, Inc. (SILO) |
US |
$0.006B |
0.00 |
| Virax Biolabs Group Limited (VRAX) |
GB |
$0.006B |
0.00 |
| Galecto, Inc. (GLTO) |
DK |
$0.006B |
0.00 |
| Avalon GloboCare Corp. (ALBT) |
US |
$0.006B |
0.00 |
| Moleculin Biotech, Inc. (MBRX) |
US |
$0.005B |
0.00 |
| Alzamend Neuro, Inc. (ALZN) |
US |
$0.005B |
0.00 |
| Aptevo Therapeutics Inc. (APVO) |
US |
$0.005B |
0.00 |
| Adial Pharmaceuticals, Inc. (ADIL) |
US |
$0.005B |
0.00 |
| Carmell Corporation (CTCX) |
US |
$0.005B |
0.00 |
| GT Biopharma, Inc. (GTBP) |
US |
$0.005B |
0.00 |
| Portage Biotech Inc. (PRTG) |
|
$0.005B |
0.00 |
| Syros Pharmaceuticals, Inc. (SYRS) |
US |
$0.005B |
0.00 |
| Novogen Limited (KZIA) |
AU |
$0.004B |
0.00 |
| Ocean Biomedical, Inc. (OCEA) |
US |
$0.004B |
0.00 |
| Sonnet BioTherapeutics Holdings, Inc. (SONN) |
US |
$0.004B |
0.00 |
| Polyrizon Ltd. (PLRZ) |
IL |
$0.004B |
0.00 |
| Allarity Therapeutics, Inc. (ALLR) |
US |
$0.004B |
0.00 |
| Purple Biotech Ltd. Sponsored ADR (PPBT) |
IL |
$0.004B |
0.00 |
| 180 Life Sciences Corp. (ATNF) |
US |
$0.004B |
0.00 |
| Synaptogenix, Inc. (SNPX) |
US |
$0.004B |
0.00 |
| Lipella Pharmaceuticals Inc. (LIPO) |
US |
$0.004B |
0.00 |
| Artelo Biosciences, Inc. (ARTL) |
US |
$0.004B |
0.00 |
| GRI Bio, Inc. (GRI) |
US |
$0.004B |
0.00 |
| CNS Pharmaceuticals, Inc. (CNSP) |
US |
$0.004B |
0.00 |
| Tharimmune, Inc. (THAR) |
US |
$0.004B |
0.00 |
| Titan Pharmaceuticals, Inc. (TTNP) |
US |
$0.003B |
0.00 |
| GENPREX (GNPX) |
US |
$0.003B |
0.00 |
| Windtree Therapeutics, Inc. (WINT) |
US |
$0.003B |
0.00 |
| Sunshine Biopharma, Inc. (SBFM) |
US |
$0.003B |
0.00 |
| Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI) |
IL |
$0.003B |
0.00 |
| Evaxion Biotech A/S Sponsored ADR (EVAX) |
DK |
$0.003B |
0.00 |
| NuCana PLC Sponsored ADR (NCNA) |
GB |
$0.003B |
0.00 |
| Lixte Biotechnology Holdings, Inc. (LIXT) |
US |
$0.003B |
0.00 |
| ZyVersa Therapeutics, Inc. (ZVSA) |
US |
$0.003B |
0.00 |
| Mustang Bio, Inc. (MBIO) |
US |
$0.003B |
0.00 |
| AquaBounty Technologies, Inc. (AQB) |
US |
$0.003B |
0.00 |
| Vincerx Pharma, Inc. (VINC) |
US |
$0.003B |
0.00 |
| NAYA Biosciences (NAYA) |
US |
$0.003B |
0.00 |
| Palisade Bio, Inc. (PALI) |
US |
$0.003B |
0.00 |
| Dermata Therapeutics, Inc. (DRMA) |
US |
$0.003B |
0.00 |
| Bone Biologics Corp. (BBLG) |
US |
$0.003B |
0.00 |
| Entero Therapeutics, Inc. (ENTO) |
US |
$0.002B |
0.00 |
| Eyenovia, Inc. (EYEN) |
US |
$0.002B |
0.00 |
| Cyclacel Pharmaceuticals, Inc. (CYCC) |
US |
$0.002B |
0.00 |
| Atrinsic Inc. (PTIX) |
US |
$0.002B |
0.00 |
| Eterna Therapeutics Inc. (ERNA) |
US |
$0.002B |
0.00 |
| Pasithea Therapeutics Corp. (KTTA) |
US |
$0.002B |
0.00 |
| Virpax Pharmaceuticals, Inc. (VRPX) |
US |
$0.001B |
0.00 |
| Hepion Pharmaceuticals, Inc. (HEPA) |
US |
$0.001B |
0.00 |
| Revelation Biosciences, Inc. (REVB) |
US |
$0.001B |
0.00 |
| Enveric Biosciences, Inc. (ENVB) |
US |
$0.001B |
0.00 |
| TFF Pharmaceuticals, Inc. (TFFP) |
US |
$0.000B |
0.00 |
| TC BioPharm (Holdings) PLC Sponsored ADR (TCBP) |
GB |
$0.000B |
0.00 |
| Aardvark Therapeutics, Inc. (AARD) |
|
$0.000B |
0.00 |
| Aceragen, Inc. (ACGN) |
US |
$0.000B |
0.00 |
| ARAVIVE, INC (ARAV) |
US |
$0.000B |
0.00 |
| Celyad SA (CYAD) |
BE |
$0.000B |
0.00 |
| Motif Bio Plc (MTFB) |
GB |
$0.000B |
0.00 |
| NeuBase Therapeutics, Inc. (NBSE) |
US |
$0.000B |
0.00 |
| PDL BioPharma, Inc. (PDLI) |
US |
$0.000B |
0.00 |
| VectivBio Holding AG (VECT) |
CH |
$0.000B |
0.00 |
| Clovis Oncology, Inc. (CLVSQ) |
US |
$0.000B |
0.00 |
